IMCC IM Cannabis
- 0.550
- -0.020-3.51%
IM Cannabis News
IM Cannabis Corp Raises Funds for German Market Growth
IM Cannabis Corp Shifts Focus to German Market
IMC Announces the Termination of a Preliminary Term Sheet With Kadimastem Ltd., a Public Company Traded on the Tel Aviv Stock Exchange to Fully Focus on the Recently Legalized German Market
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany,...
Weed Industry Celebrates Biden's Rescheduling Move: 'Most Monumental Cannabis Reform In Half A Century'
Cannabis companies and legalization advocates are applauding President Joe Biden's Thursday announcement that formalizes the rescheduling process that will finally move cannabis from the DEA's Schedu
Weed Stocks Rally After Biden Makes Marijuana Reclassification Announcement
Shares of marijuana growers and cannabis-related companies are trading higher Thursday after President Biden announced that the Department of Justice has moved to reclassify marijuana from a Schedule
Express News | Shares of Cannabis Stocks Are Trading Higher After Biden Said the Justice Department Is Taking the Next Steps to Reclassify Marijuana From Schedule I to Schedule III
Express News | President Biden Posts On X "Too Many Lives Have Been Upended Because Of Our Failed Approach To Marijuana. So Today, The @TheJusticeDept Is Taking The Next Step To Reclassify Marijuana From A Schedule I To A Schedule Iii Drug Under Federal Law."
Express News | 'DEA Appears To Question Marijuana's Medical Value Despite Rescheduling Recommendation' - Marijuana Moment
IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue
IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) reported a 13% sequential increase in revenue for the three months ended March 31, 2024, hitting CA$10.7 million ($7.8 million). That is, however, a 4% decre
IM Cannabis Optimistic as Revenue and Profits Rise
IM Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
IM Cannabis Q1 EPS $(0.31) Misses $(0.20) Estimate, Sales $8.95M Miss $10.60M Estimate
IM Cannabis (NASDAQ:IMCC) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.20) by 55 percent. This is a 1650 percent decrease over earnings of $0.02 pe
IM Cannabis 1Q Loss/Shr 42c >IMCC.L
IM Cannabis 1Q Loss/Shr 42c >IMCC.L
IM Cannabis 1Q Rev $12.1M >IMCC.L
IM Cannabis 1Q Rev $12.1M >IMCC.L
Press Release: IM Cannabis Reports First Quarter Financial Results
IM Cannabis Reports First Quarter Financial Results PR Newswire TORONTO and GLIL YAM, Israel, May 8, 2024 IMC prepares for accelerated growth after legalization in Germany and recovers from the imp
Newsweek Reporter Kevin Sabet Says On X "I Can Now Say With Full Confidence That The Administrator Of DEA, Anne Milgram, Did Not Sign The Rescheduling Order, Breaking With Five Decades Of Precedent And Established Law And Regulations (Two Confidential...
Newsweek Reporter Kevin Sabet Says On X "I Can Now Say With Full Confidence That The Administrator Of DEA, Anne Milgram, Did Not Sign The Rescheduling Order, Breaking With Five Decades Of Precedent An
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
Shares of Aspen Aerogels, Inc. (NYSE:ASPN) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.Aspen Aerogels posted a GAAP loss
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) fell sharply during Wednesday's session as the company reported first-quarter results and issued revenue guidance for the second quarter.AMD guided
What's Going On With IM Cannabis Stock?
IM Cannabis Corp. (NASDAQ:IMCC) shares are trading higher Wednesday, and the stock is up more than 100% over the past five days. Here's a look at what's going on. The Details:Cannabis stocks soared Tu
Express News | 'Declassifying Cannabis Still Leaves Pot Stocks In Limbo' - Wall Street Journal
Analysis
Price Target
No Data
